Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

DNA Microarrays02:34

DNA Microarrays

16.8K
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
16.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis.

Molecular neurodegeneration·2026
Same author

Microglial Extracellular Vesicles Mediate C1q Deposition at the Pre-Synapse and Promote Synaptic Pruning.

Journal of extracellular vesicles·2025
Same author

Affinity-Based Copolymer Coating for Oriented Protein Immobilization in Biosensor Development.

Biosensors·2025
Same author

Spotlight on innovation: key insights from the extracellular vesicle cluster meeting at the European Innovation Council.

Cytotherapy·2025
Same author

Machine learning-assisted assessment of extracellular vesicles can monitor cellular rejection after heart transplant.

Communications medicine·2025
Same author

Affinity-Based Isolation and One-Pot Analysis of Extracellular Vesicles from Biofluids Using Phase Separated Zwitterionic Coacervates.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same journal

Aptamer-based CRISPR-Cas12a fluorescent biosensors for serum biomarker detection.

The Analyst·2026
Same journal

A two-step centrifugal microfluidic platform for semi-automated IGRA detection of tuberculosis based on chemiluminescence.

The Analyst·2026
Same journal

On-site rapid identification of animal and plant creams <i>via</i> 2D FeB nanozyme-based colorimetric sensors.

The Analyst·2026
Same journal

Sensitive detection of aflatoxin B1 using a dual-mode fluorescent aptasensor based on cascade signal amplification.

The Analyst·2026
Same journal

Deep learning-enabled microfluidic digital PCR platform for efficient seven-color quantification.

The Analyst·2026
Same journal

Monitoring food spoilage biogenic amines utilizing a blue-emitting fluorescent ionic liquid.

The Analyst·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.2K

Protein microarray technology: how far off is routine diagnostics?

Marina Cretich1, Francesco Damin, Marcella Chiari

  • 1Consiglio Nazionale delle Ricerche, Istituto di Chimica del Riconoscimento Molecolare (ICRM), CNR, Via Mario Bianco, 9, 20131, Milano, Italy. marina.cretich@icrm.cnr.it.

The Analyst
|December 12, 2013
PubMed
Summary
This summary is machine-generated.

Protein microarrays offer potential for personalized medicine and diagnostics. This review addresses key challenges in their clinical application, including quality control, reagent issues, and automation, to facilitate broader adoption in vitro diagnostics (IVD).

More Related Videos

Performing Custom MicroRNA Microarray Experiments
07:04

Performing Custom MicroRNA Microarray Experiments

Published on: October 28, 2011

19.2K
Identification of Mycobacterium Species by DNA Microarray Chip Method
06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

802

Related Experiment Videos

Last Updated: May 5, 2026

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray
07:35

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

12.2K
Performing Custom MicroRNA Microarray Experiments
07:04

Performing Custom MicroRNA Microarray Experiments

Published on: October 28, 2011

19.2K
Identification of Mycobacterium Species by DNA Microarray Chip Method
06:27

Identification of Mycobacterium Species by DNA Microarray Chip Method

Published on: June 24, 2025

802

Area of Science:

  • Biotechnology
  • Medical Diagnostics
  • Bioanalytical Chemistry

Background:

  • Protein microarrays are powerful platforms for multiplexed biomarker detection, enabling advancements in personalized medicine and diagnostics.
  • Despite their potential, the clinical translation of protein microarray technology into the in vitro diagnostics (IVD) market remains limited.
  • Several operational challenges hinder the widespread adoption of protein microarrays in clinical settings.

Purpose of the Study:

  • To review the critical operational challenges impacting the clinical utility of protein microarrays.
  • To identify key areas for improvement in microarray assay development and implementation for in vitro diagnostics.
  • To provide an overview of current microarray assays and diagnostic products relevant to the IVD market.

Main Methods:

  • Literature review focusing on operational challenges in protein microarray development and application.
  • Analysis of critical factors including probe printing, quality control, bio-reagent procurement, and antibody cross-reactivity.
  • Examination of mass transport limitations, assay automation, calibration, and quantification in microarray assays.
  • Compilation of existing microarray assays and commercially available diagnostic products for in vitro diagnostics.

Main Results:

  • Key challenges identified include ensuring probe printing quality, managing bio-reagent sourcing and antibody specificity, overcoming mass transport limitations, and establishing robust automation and calibration protocols.
  • The review highlights the need for standardized procedures and rigorous quality control measures for reliable clinical application.
  • A selection of relevant IVD microarray assays and a summary of current market products are presented.

Conclusions:

  • Addressing the identified operational challenges is crucial for the successful integration of protein microarrays into routine clinical diagnostics.
  • Standardization and validation of microarray platforms are essential to overcome barriers to market entry for in vitro diagnostics.
  • Further development in automation, reagent quality, and assay calibration will accelerate the clinical adoption of protein microarray technology.